Balziva
Product Images NDC 53002-1725

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Balziva (NDC 53002-1725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

00555903458part1of2

Balziva tablet shown from front and back. One side is imprinted with a lowercase letter 'b', the other side is imprinted with the numbers '735'. The tablet is round, peach-colored, and measures approximately 6 mm in diameter. The product is labeled by RPK Pharmaceuticals, Inc.*

FDA Label Image

00555903458part2of2

Image of a white, round tablet identified as Balziva. One side is imprinted with a lowercase letter 'b' inside a hexagonal shape, and the other side is imprinted with the number '944'. The tablet size is approximately 9-10 mm in diameter. Labeler is RPK Pharmaceuticals, Inc.*

FDA Label Image

Structural Formulas (Image 1)

Chemical structure diagrams of the active ingredients of Balziva. The image shows two steroidal molecular structures labeled with hydroxyl groups, methyl groups, and other chemical bonds, representing components of this pharmaceutical product by RPK Pharmaceuticals, Inc.*

FDA Label Image

Figure 1: Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Image 2)

A bar chart comparing mortality rates (number of deaths per 100,000 woman years) by age group (15-24, 25-34, 35-44, 45+) for four categories: Ever-Users (Nonsmokers), Controls (Nonsmokers), Ever-Users (Smokers), and Controls (Smokers). Mortality rate increases with age, with Ever-Users (Smokers) showing the highest rates across age groups.*

FDA Label Image

Blister Image (Image 3)

Balziva 0.4 mg/0.035 mg tablets packaging label displaying a 28-day pill blister pack for norethindrone and ethinyl estradiol tablets USP. The blister pack is marked by day of the week from Sunday to Saturday and includes instructions to take all colored pills before taking any white pills. The label includes storage instructions at 20° to 25°C and indicates the product is prescription only, from RPK Pharmaceuticals, Inc.*

FDA Label Image

Label Image (Lbl530021725)

Balziva 0.04/0.035 mg tablets 28-day regimen in a 1-month pack by RPK Pharmaceuticals, Inc. The label states "Take 1 tablet daily as directed" with space for patient name, clinic name, and prescription details. It includes NDC 53002-1725 and barcode for identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.